Financials Japan Medical Dynamic Marketing, INC.

Equities

7600

JP3689100000

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 00:03:13 2024-04-30 EDT 5-day change 1st Jan Change
675 JPY +0.15% Intraday chart for Japan Medical Dynamic Marketing, INC. -0.15% -11.07%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 26,269 28,645 43,138 59,759 43,217 27,379
Enterprise Value (EV) 1 28,398 30,914 44,757 60,381 42,474 26,445
P/E ratio 18.4 x 14.4 x 19.9 x 35.9 x 20.2 x 19.3 x
Yield 0.8% 0.83% 0.61% 0.49% 0.73% 1.25%
Capitalization / Revenue 1.77 x 1.71 x 2.39 x 3.57 x 2.25 x 1.28 x
EV / Revenue 1.92 x 1.85 x 2.48 x 3.61 x 2.21 x 1.24 x
EV / EBITDA 9.28 x 9.1 x 11.1 x 17 x 10.4 x 7.4 x
EV / FCF 24.8 x -58.4 x 235 x 95.1 x 113 x 2,460 x
FCF Yield 4.03% -1.71% 0.42% 1.05% 0.88% 0.04%
Price to Book 1.99 x 1.89 x 2.55 x 3.21 x 2.02 x 1.18 x
Nbr of stocks (in thousands) 26,401 26,401 26,384 26,384 26,384 26,301
Reference price 2 995.0 1,085 1,635 2,265 1,638 1,041
Announcement Date 18-06-25 19-06-25 20-06-23 21-06-22 22-06-28 23-06-27
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 14,807 16,728 18,083 16,738 19,193 21,307
EBITDA 1 3,059 3,397 4,033 3,557 4,082 3,573
EBIT 1 2,045 2,235 2,645 2,169 2,662 2,024
Operating Margin 13.81% 13.36% 14.63% 12.96% 13.87% 9.5%
Earnings before Tax (EBT) 1 1,731 2,168 2,614 2,033 2,749 1,769
Net income 1 1,425 1,984 2,164 1,664 2,135 1,423
Net margin 9.62% 11.86% 11.97% 9.94% 11.12% 6.68%
EPS 2 53.98 75.15 81.99 63.07 80.92 54.00
Free Cash Flow 1 1,144 -529.1 190.1 635 375 10.75
FCF margin 7.72% -3.16% 1.05% 3.79% 1.95% 0.05%
FCF Conversion (EBITDA) 37.39% - 4.71% 17.85% 9.19% 0.3%
FCF Conversion (Net income) 80.25% - 8.79% 38.16% 17.56% 0.76%
Dividend per Share 2 8.000 9.000 10.00 11.00 12.00 13.00
Announcement Date 18-06-25 19-06-25 20-06-23 21-06-22 22-06-28 23-06-27
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 S1 2024 Q3
Net sales 1 8,782 9,301 7,753 8,985 4,321 8,858 5,120 5,215 10,335 5,027 4,962 9,989 5,635 5,683 11,318 5,403 10,952 6,041
EBITDA - - - - - - - - - - - - - - - - - -
EBIT 1 1,266 1,378 823 1,345 504 1,058 933 670 1,603 498 429 927 583 514 1,097 346.4 617 566
Operating Margin 14.42% 14.82% 10.62% 14.97% 11.66% 11.94% 18.22% 12.85% 15.51% 9.91% 8.65% 9.28% 10.35% 9.04% 9.69% 6.41% 5.63% 9.37%
Earnings before Tax (EBT) 1 1,275 - 788 - - 1,326 872 - - 478 - 932 608 - - 253 539 582
Net income 1 922 1,242 526 1,138 640 1,003 631 501 1,132 336 385 721 417 285 702 177.3 359 373
Net margin 10.5% 13.35% 6.78% 12.67% 14.81% 11.32% 12.32% 9.61% 10.95% 6.68% 7.76% 7.22% 7.4% 5.01% 6.2% 3.28% 3.28% 6.17%
EPS 2 34.93 - 19.95 - - 38.03 23.92 - - 12.75 - 27.35 15.85 - - 6.740 13.67 14.18
Dividend per Share - - - - - - - - - - - - - - - - - -
Announcement Date 19-10-31 20-04-30 20-10-30 21-04-30 21-10-29 21-10-29 22-01-31 22-04-28 22-04-28 22-07-29 22-10-31 22-10-31 23-01-31 23-04-28 23-04-28 23-07-28 23-10-30 24-01-31
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 2,129 2,269 1,619 622 - -
Net Cash position 1 - - - - 743 934
Leverage (Debt/EBITDA) 0.696 x 0.6679 x 0.4014 x 0.1749 x - -
Free Cash Flow 1 1,144 -529 190 635 375 10.8
ROE (net income / shareholders' equity) 11.2% 14% 13.6% 9.41% 10.7% 6.41%
ROA (Net income/ Total Assets) 6.03% 6.3% 6.83% 5.41% 6.33% 4.46%
Assets 1 23,640 31,504 31,685 30,755 33,708 31,934
Book Value Per Share 2 501.0 575.0 642.0 706.0 811.0 881.0
Cash Flow per Share 2 93.10 85.60 95.20 93.50 98.20 107.0
Capex 1 1,001 1,977 1,654 1,348 1,539 1,222
Capex / Sales 6.76% 11.82% 9.15% 8.05% 8.02% 5.74%
Announcement Date 18-06-25 19-06-25 20-06-23 21-06-22 22-06-28 23-06-27
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 7600 Stock
  4. Financials Japan Medical Dynamic Marketing, INC.